Dilip Buildcon Ltd.: Q3FY18 Result Update

Similar documents
PNC Infratech Ltd.: Q3FY18 Result Update

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

Jindal Stainless Hisar Ltd.: Q3FY18 Result Update

Trident Ltd: Q2FY18 Result Update

Trident Ltd.: Q1FY18 Result Update

Economic Spotlight. Current Account Deficit Narrows. Edelweiss Investment Research

Transformer and Rectifier (India) Ltd: Q4FY17 Result Update

Economic Spotlight. Revised Govt. Borrowing Means More Fiscal Room. Edelweiss Investment Research

RELIANCE INDUSTRIES LIMITED

JSW Steel EDELSTAR FUNDAMENTAL RESEARCH

Ratnamani Metals & Tubes Ltd.: Q1FY18 Results Update

Zee Learn Ltd.: Q2FY18 Result Update

Emami Ltd. EDELSTAR FUNDAMENTAL RESEARCH

Kirloskar Brothers Ltd.: Q1FY18 Result Update

Performance Tracker Equity

First Flash: Butterfly Gandhimathi Appliances Ltd

Kirloskar Brothers Ltd.: Q4FY17 Result Update

S.P.Apparels Ltd. Q1FY18 Result Update

S P Apparels Ltd.: Q2FY18 Result Update

Edelweiss Investment Research Stock view: Axis Bank Ltd. Axis Bank Ltd.

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Cummins India Ltd Bloomberg Code: KKC IN

Adani Ports & SEZ Rating: Target price: EPS:

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

Visaka Industries Ltd

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Fineotex Chemical Ltd

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Amber Enterprises India Ltd

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

Jamna Auto Industries

Gillette India. Institutional Equities. 1QFY18 Result Update

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Institutional Equities

Colgate-Palmolive (India)

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

Change EPS. (Rs) FY

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation

BUY MULTI COMMODITY EXCHANGE OF INDIA. Demonetization,GST uncertainty impact Q4. Target Price: Rs 1,397. Concall highlights

Ahluwalia Contracts (India)

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Dr Reddy s Laboratories

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

BUY. Outperformance continues GULF OIL LUBRICANTS INDIA. Target Price: Rs 1,000. Hike estimates and TP; maintain BUY

Wipro. 4QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 287. Recommendation: Hold

HCL Technologies. Rating: Target price: EPS: Target CMP. Rating. Rs. 826 REDUCE. Rs.760

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

Simplex Infrastructures

Key estimate revision. Year FY14 23,28,609 3,48,027 1,40, FY15E 25,74,029 3,94,133 1,69,

BUY MULTI COMMODITY EXCHANGE OF INDIA. Strong Q2; All eyes on option volumes. Target Price: Rs 1,280. Concall highlights

Key estimate revision. Financial summary. Year FY15 121, % 16, % FY16E 137, % 20,

Key estimate revision. Financial summary. Year

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9,

Indian Oil Corporation

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Balkrishna Industries

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

He is BTech from IIT Bombay ( , Aeronautical Engineering) and MS from Cornell University ( , Mechanical Engineering).

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

HOLD PVR. Operating matrix healthy; footfalls subdued. Target Price: Rs 1,520. Key highlights

HINDUSTAN UNILEVER Indulekha allure for the tresses

HOLD. Performance remains weak COLGATE-PALMOLIVE INDIA. Target Price: Rs 900

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Bayer Cropscience (BYRCS IN)

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

PGCIL Order Inflow Analysis

Mahindra & Mahindra Ltd.

Near-term pressure, but long-term outlook positive

Indo Count Industries BUY

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

ITC Ltd. RESULT UPDATE 27th October, 2017

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

MCX Ltd. Rating: Target price: EPS: Is commodity option a game changer for MCX? - Unlikely. Target. Rating CMP. Rs. 1,080 SELL. Rs.

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

Robust results, TLT margins improved profitability.

BUY. Strong quarter, bright outlook MAHINDRA CIE AUTOMOTIVE. Target Price: Rs 274. Takeaways from concall. Key drivers (%)

Wipro. 3QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 328. Recommendation: Hold

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

Hold Target Price: Rs 574

ITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs.

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

Mahindra & Mahindra Ltd.

Skipper Ltd. May 17, Towering high. CMP INR 205 Target INR 238 Result Update - BUY. Company Background. Investment Rationale

Techno Electric & Engineering Limited

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Colgate-Palmolive India Ltd.

Symphony Ltd. RESULT UPDATE 31st October 2017

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

Transcription:

Edelweiss Investment Research Dilip Buildcon Ltd.: Q3FY18 Result Update From Sub-contractor to Marquee EPC Play CMP INR: 981 Rating: BUY Target Price INR: 1,204 Upside: 22% Dilip Buildcon (DBL), the largest road EPC / HAM contractor in India with INR 15,500 cr of order-book and INR 5.098 cr revenue (FY17) declared their Q3FY18 results. Topline grew by whopping 40% YoY to INR 1,942 cr and way better than our expectations of 25% YoY growth. Higher than expected growth in revenue on a storng base (topline growth in Q3FY17 was 42% YoY) is commendable in our view. Due to high other expenses, EBITDA margin came under pressure by 200 bps YoY to 17.7% in Q3FY18 and EBITDA grew by 24% YoY. High financial leverage and low tax payments aid the PAT to grow by 52% YoY to INR 167 cr against our expectations of INR 135 cr. The company reported PAT margin 8.5%, which is the highest third quarter margin reported since listing. Management maintained thier FY18E topline guidance at INR 7,000 cr. Based on strong track record and 55% growth reported in first nine months, we are revising our FY18E topline expectations to INR 7,240 cr (42% growth YoY) against INR 6,926 cr expected earlier. Gross debt level of the company further increased to INR 3,165 cr as delay in GST payment and delay in gettng appointed date in 4 HAM projetcs affected the working capital cycle in the previous quarter and hence management increased the Gross debt guidance for FY18E to INR 2,500-2,600 cr against INR 2,200-2,300 cr earlier. We believe, DBL is best placed to capture growth in construction expenditure both by central and state governments. We reiterate our BUY recommendation with a revised target price of INR 1,204/share. Current Order book offers more than 3 years of revenue visibility; Management expect INR 8,000-10,000 cr Order-inflow in FY18E DBL reported total order book of INR 12,357 cr at the end of Q3FY18. The company has also reported INR 3,173 cr of order inflow post the third quarter and with that overall order book currently stands at INR 15,500 cr which offers more than 3 years of revenue visibility. 80% of the orders are form road segment whereas 16% are from mining segment. For the full year of FY18E, management is expecting to have INR 8,000-10,000 cr of order inflow majorly in the road space as ordering activity is expected to pick up pace going forward. Apart from road sector, the company is actively seeking opportunity in the river linking and mining projects which are expected to drive FY19E order book high. Superior execution push the revenue growth high; Outlook improved further DBL reported standalone topline growth of 40% YoY to INR 1,942 cr in Q3FY18 as projects won earlier across the road and mining segment started showing traction. Revenue from road segment grew by 34% YoY to INR 1,692 cr and Mining segment reported INR 218 cr revenue against INR 47 cr reported corresponding quarter last year. We believe, considering the high order-book and overall traction in the construction space, topline of the company would report 42% YoY growth to INR 6,240 cr backed by 37% growth in road segment and 400% growth in mining segment. We also revised our FY19E topline to INR 8,900 cr from INR 8,493 cr earlier. We believe, EBITDA margin FY18E and FY19E will remain at 18% which is similar to lower end of management guidance. Debashish Mazumdar Research Analyst debashish.mazumdar@edelweissfin.com Bloomberg: 52-week range (INR): Share in issue (cr): DBL:IN 1,059.00 / 254.05 14 M cap (INR cr): 13,345 Avg. Daily Vol. BSE/NSE :( 000): Promoter Holding (%) 300 75.63 Asset Monetization, Limited Capex to aid containing elevated debt levels going forward Due to higher working capital requirement backed by strong execution and delay in getting appointed date in 4 HAM projects, debt level got elevated further to INR 3,165 cr in Q3FY18. We believe, with the inflow of INR 250-300 cr from asset sales and recovery of GST receivables, gross debt will come down to INR 2,600 cr in FY18E and INR 2,500 cr in FY19E. NWC of the company has improved significantly and expected to improve further going forward backed by recovery of stuck money and improvement in inventory cycle. With the growth in profitability, limited capex and NWC improvement, overall RoCE is expected to improve to 23% in FY19E as compared to 18% achieved in FY17. Valuation: Maintain BUY with a revised target price of INR 1,204 At CMP of INR 981, the stock is trading at 19x of FY19E and 15x of FY20E EPS. The standalone EPC business, without considering the cash+ equity contribution of INR 1,600 cr from asset sales is trading at 17x of FY19E and 14x of FY20E expected EPS of INR 53 and INR 64 respectively. We reiterate BUY with a revised target price of INR 1,204/share Year to March Q3FY18 Q3FY17 Net Revenues (INR cr) % change Q2FY18 % change FY18E FY19E FY20E 1,942 1,389 40% 1,582 23% 7,240 8,900 10,981 EBITDA (INR crs.) 345 278 24% 291 18% 1,325 1,602 1,977 PAT (INR Crs) 165 109 52% 122 35% 599 718 867 Diluted EPS (INR) 43.8 52.5 63.4 Diluted PE (x) 22.4 18.7 15.5 EV/EBITDA 9.2 7.2 5.8 ROE(%) 24% 23% 21% Date: 14 th February 2018 1 GWM

Dilip Buildcon Ltd. Q3FY18 Result Highlights Particulars Q3FY18 Q3FY17 %Change Q1FY18 %Change 9MFY18 9MFY17 %Change Net Revenues 1,942 1,389 40% 1,582 23% 5,188 3,347 55% Direct Expenses 1,494 1,037 44% 1,218 23% 3,989 2,492 60% Gross Profit 448 352 27% 363 23% 1,199 855 40% Operating Expenses 104 75 39% 72 44% 262 218 20% EBITDA 345 278 24% 291 18% 936 637 47% Depreciation 70 59 18% 68 3% 202 166 22% Interest 117 106 10% 111 5% 338 310 - Other Income 6 3 112% 3 80% 11 8 39% PBT 164 115 43% 116 41% 407 169 140% Tax Payment -1 6-115% -6-84% -2 4-148% PAT Before Minority & Associate Share 165 109 52% 122 35% 409 165 148% Share of Associates 0 0-0 NA 0 0 - Reported PAT 165 109 52% 122 35% 409 165 148% Equity Capital 137 137-137 - 137 137 - No of Shares 14 14-14 0% 14 14 - EPS 12.0 7.9 52% 8.89 35% 29.9 12.1 148% EBITDA Margin 18% 20% 18% 18% 19% PAT Margin 8% 8% 8% 8% 5% Tax Rate -1% 5% -5% -1% 3% Other Key Highlights: Central Government is expected to award 35,000 km of highways over the period of next two years and DBL is expected get a reasonable market share in that. In FY17 awarding runrate was 25km/day (both EPC and HAM) and the company got 10% market share in that. Currently the company has INR 50,000 cr of bid pipeline and among that 80% are in EPC and 20% are in HAM mode. Management is confident of adding INR 8,000 cr of EPC projects and INR 4,000 cr of HAM projects in the medium term. Among the six HAM projects, all projects got financial closure. And except one all of them got appointed date in December. The remaining one HAM projects is also expected to get appointed date by the end of February, 2018 Receivable days came down to 74 days as compared to 95 days last year and the company has received INR 11 cr from past stuck receivables. DBL also wrote of INR 130 cr from the stuck debtors. Inventory days have come down by 36 days YoY to 103 days as execution of large projects reduces the aggregate inventory. The company sold all its BOT/HAM assets with a total consideration of INR 1,600 cr and among that INR 200 cr has already been received and another INR 250-300 cr is expected to come in Quarter four. Change in Estimates FY18E FY19E Previous New Deviation Previous New Deviation Revenue 6,926 7,240 5% 8,493 8,900 5% EBITDA 1,247 1,325 6% 1,529 1,602 5% Core Profit 520 599 15% 680 718 6% 2 GWM

Dilip Buildcon Ltd. Financials Income Statement (Standalone) (INR cr) Income from operations 4,085 5,098 7,240 8,900 10,981 Direct Expenses 3,000 3,793 5,503 6,675 8,126 Employee Cost 87 102 159 178 275 Other Expenses 198 210 253 445 604 Total operating expenses 3,286 4,105 5,915 7,298 9,005 EBITDA 799 992 1,325 1,602 1,977 Depreciation and amortisation 183 227 272 287 316 EBIT 616 765 1,052 1,315 1,661 Interest expenses 381 416 450 435 448 Other income 16 11 15 18 25 Profit before tax 250 360 618 898 1,238 Provision for tax 29-1 19 180 371 Core profit 221 361 599 718 867 Extraordinary items 0 0 0 0 0 Profit after tax 221 361 599 718 867 Minority Interest 0 0 0 0 0 Share from associates 0 0 0 0 0 Adjusted net profit 221 361 599 718 867 Equity shares outstanding (Crs) 13.7 13.7 13.7 13.7 13.7 EPS (INR) basic 16.1 26.4 43.8 52.5 63.4 Diluted shares (Crs) 13.7 13.7 13.7 13.7 13.7 EPS (INR) fully diluted 16.1 26.4 43.8 52.5 63.4 Dividend per share 0.0 0.0 0.0 0.0 0.0 Dividend payout (%) 0.0 0.0 0.0 0.0 0.0 Common size metrics- as % of net revenues Operating expenses 80.4 80.5 81.7 82.0 82.0 Depreciation 4.5 4.5 3.8 3.2 2.9 Interest expenditure 9.3 8.2 6.2 4.9 4.1 EBITDA margins 19.6 19.5 18.3 18.0 18.0 Net profit margins 5.4 7.1 8.3 8.1 7.9 Growth metrics (%) Revenues 55.7 24.8 42.0 22.9 23.4 EBITDA 41.3 24.1 33.5 20.9 23.4 PBT 28.3 44.0 71.6 45.3 37.9 Net profit after minority interest 51.5 63.5 66.1 19.9 20.6 EPS 51.5 63.5 66.1 19.9 20.6 Profit & Efficiency Ratios (Standalone) ROAE (%) 21% 19% 24% 23% 21% ROACE (%) 18% 17% 20% 23% 26% Debtors (days) 81 73 73 73 73 Current ratio 1.9 1.9 2.2 2.3 2.5 Gross Debt/Equity 2.1 1.2 1.0 0.8 0.6 Inventory (days) 141 119 92 91 90 Payable (days) 91 64 46 45 44 Cash conversion cycle (days) 131 128 120 119 119 Gross Debt/EBITDA 2.8 2.2 1.9 1.6 1.3 Net debt/equity 2.0 1.1 0.9 0.7 0.5 Balance Sheet (Standalone) (INR cr) As on 31st March FY16 FY17 FY18E FY19E FY20E Equity share capital 117 137 137 137 137 Warrants 0 0 0 0 0 Reserves & surplus 945 1,716 2,315 3,034 3,901 Shareholders funds 1,062 1,853 2,452 3,171 4,037 Borrowings 2,518 2,697 2,997 2,897 2,797 Minority interest 0 0 0 0 0 Sources of funds 3,581 4,550 5,450 6,068 6,835 Gross block 1,940 2,424 2,724 3,024 3,324 Depreciation 519 742 1,014 1,302 1,618 Net block 1,420 1,682 1,710 1,723 1,707 Capital work in progress 0 0 10 20 30 Total fixed assets 1,420 1,682 1,720 1,743 1,737 Goodwill 0 0 0 0 0 Non Current Assets 575 977 1,077 1,077 1,077 Inventories 1,579 1,664 1,834 2,225 2,709 Sundry debtors 912 1,017 1,448 1,780 2,196 Cash and equivalents 106 114 280 335 437 Loans and advances 502 888 1,256 1,316 1,376 Other current assets 0 0 0 0 0 Total current assets 3,099 3,682 4,818 5,656 6,717 Sundry creditors and others 1,697 2,091 2,165 2,408 2,696 Provisions 7 8 0 0 0 Total CL & provisions 1,703 2,099 2,165 2,408 2,696 Net current assets 1,396 1,583 2,653 3,249 4,021 Net Deferred tax 0 0 0 0 0 Misc expenditure 0 0 0 0 0 Uses of funds 3,391 4,242 5,450 6,068 6,835 Book value per share (INR) 248 310 398 444 500 Cash flow statement (INR cr) Net profit 221 361 599 718 867 Add: Depreciation 183 227 272 287 316 Add: Interest net of tax 337 417 436 348 313 Add: Deferred tax 0 0 0 0 0 Add: Others 94 28 75 75 75 Gross cash flow 836 1,034 1,383 1,428 1,571 Less: Changes in W. C. 414 298 596 540 671 Operating cash flow 421 735 787 888 899 Less: Capex 411 485 300 300 300 Less: Investment in subsidiaries -50 402 100 0 0 Free cash flow 60-151 387 588 599 Valuation Parameters (Stanalone) Diluted EPS (INR) 18.9 26.4 43.8 52.5 63.4 Y-o-Y growth (%) 51.5 40.0 66.1 19.9 20.6 CEPS (INR) 34.5 43.0 63.7 73.5 86.5 Diluted P/E (x) 39.0 23.9 22.4 18.7 15.5 Price/BV(x) 8.1 4.7 5.5 4.2 3.3 EV/Sales (x) 2.6 2.1 2.2 1.8 1.4 EV/EBITDA (x) 12.5 12.3 9.2 7.2 5.8 Diluted shares O/S 13.7 13.7 13.7 13.7 13.7 Basic EPS 18.9 26.4 43.8 52.5 63.4 Basic PE (x) 39.0 23.9 22.4 18.7 15.5 Dividend yield (%) 0% 0% 0% 0% 0% 3 GWM

Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 (Indexed) Edelweiss Broking Limited, 1st Floor, Tower 3, Wing B, Kohinoor City Mall, Kohinoor City, Kirol Road, Kurla(W) Board: (91-22) 4272 2200 Vinay Khattar Head Research vinay.khattar@edelweissfin.com Rating Buy Hold Reduce Expected to appreciate more than 15% over a 12-month period appreciate between 5-15% over a 12-month period Return below 5% over a 12-month period 450 400 350 300 250 200 150 100 50 0 Dilip Buildcon Sensex 4 GWM

Disclaimer Edelweiss Broking Limited ( EBL or Research Entity ) is regulated by the Securities and Exchange Board of India ( SEBI ) and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its Associates (list available on www.edelweissfin.com) are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. Broking services offered by Edelweiss Broking Limited under SEBI Registration No.: INZ000005231; Name of the Compliance Officer: Mr. Brijmohan Bohra, Email ID: complianceofficer.ebl@edelweissfin.com Corporate Office: Edelweiss House, Off CST Road, Kalina, Mumbai - 400098; Tel. 18001023335/022-42722200/022-40094279 This Report has been prepared by Edelweiss Broking Limited in the capacity of a Research Analyst having SEBI Registration No.INH000000172 and distributed as per SEBI (Research Analysts) Regulations 2014. This report does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. The information contained herein is from publicly available data or other sources believed to be reliable. This report is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. The investment discussed or views expressed may not be suitable for all investors. This information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject EBL and associates / group companies to any registration or licensing requirements within such jurisdiction. The distribution of this report in certain jurisdictions may be restricted by law, and persons in whose possession this report comes, should observe, any such restrictions. The information given in this report is as of the date of this report and there can be no assurance that future results or events will be consistent with this information. This information is subject to change without any prior notice. EBL reserves the right to make modifications and alterations to this statement as may be required from time to time. EBL or any of its associates / group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. EBL is committed to providing independent and transparent recommendation to its clients. Neither EBL nor any of its associates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct, indirect, special or consequential including loss of revenue or lost profits that may arise from or in connection with the use of the information. Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Past performance is not necessarily a guide to future performance.the disclosures of interest statements incorporated in this report are provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The information provided in these reports remains, unless otherwise stated, the copyright of EBL. All layout, design, original artwork, concepts and other Intellectual Properties, remains the property and copyright of EBL and may not be used in any form or for any purpose whatsoever by any party without the express written permission of the copyright holders. EBL shall not be liable for any delay or any other interruption which may occur in presenting the data due to any reason including network (Internet) reasons or snags in the system, break down of the system or any other equipment, server breakdown, maintenance shutdown, breakdown of communication services or inability of the EBL to present the data. In no event shall EBL be liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data presented by the EBL through this report. We offer our research services to clients as well as our prospects. Though this report is disseminated to all the customers simultaneously, not all customers may receive this report at the same time. We will not treat recipients as customers by virtue of their receiving this report. EBL and its associates, officer, directors, and employees, research analyst (including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company(ies), mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company(ies) discussed herein or act as advisor or lender/borrower to such company(ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. EBL may have proprietary long/short position in the above mentioned scrip(s) and therefore should be considered as interested. The views provided herein are general in nature and do not consider risk appetite or investment objective of any particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business with EBL. EBL or its associates may have received compensation from the subject company in the past 12 months. EBL or its associates may have managed or co-managed public offering of securities for the subject company in the past 12 months. EBL or its associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report. Research analyst or his/her relative or EBL s associates may have financial interest in the subject company. EBL, its associates, research analyst and his/her relative may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. Participants in foreign exchange transactions may incur risks arising from several factors, including the following: ( i) exchange rates can be volatile and are subject to large fluctuations; ( ii) the value of currencies may be affected by numerous market factors, including world and national economic, political and regulatory events, events in equity and debt markets and changes in interest rates; and (iii) currencies may be subject to devaluation or government imposed exchange controls which could affect the value of the currency. Investors in securities such as ADRs and Currency Derivatives, whose values are affected by the currency of an underlying security, effectively assume currency risk. Research analyst has served as an officer, director or employee of subject Company: No EBL has financial interest in the subject companies: No EBL s Associates may have actual / beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report. Research analyst or his/her relative has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No EBL has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No Subject company may have been client during twelve months preceding the date of distribution of the research report. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. A graph of daily closing prices of the securities is also available at www.nseindia.com Analyst Certification: The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. Additional Disclaimer for U.S. Persons Edelweiss is not a registered broker dealer under the U.S. Securities Exchange Act of 1934, as amended (the 1934 act ) and under applicable state laws in the United States. In addition Edelweiss is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under 5 GWM

Disclaimer applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Edelweiss, including the products and services described herein are not available to or intended for U.S. persons. This report does not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules. Transactions in securities discussed in this research report should be effected through Edelweiss Financial Services Inc. Additional Disclaimer for U.K. Persons The contents of this research report have not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 ("FSMA"). In the United Kingdom, this research report is being distributed only to and is directed only at (a) persons who have professional experience in matters relating to investments falling within Article 19(5) of the FSMA (Financial Promotion) Order 2005 (the Order ); (b) persons falling within Article 49(2)(a) to (d) of the Order (including high net worth companies and unincorporated associations); and (c) any other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as relevant persons ). This research report must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this research report relates is available only to relevant persons and will be engaged in only with relevant persons. Any person who is not a relevant person should not act or rely on this research report or any of its contents. This research report must not be distributed, published, reproduced or disclosed (in whole or in part) by recipients to any other person. Additional Disclaimer for Canadian Persons Edelweiss is not a registered adviser or dealer under applicable Canadian securities laws nor has it obtained an exemption from the adviser and/or dealer registration requirements under such law. Accordingly, any brokerage and investment services provided by Edelweiss, including the products and services described herein, are not available to or intended for Canadian persons. This research report and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services. Disclosures under the provisions of SEBI (Research Analysts) Regulations 2014 (Regulations) Edelweiss Broking Limited ("EBL" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its associates are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. This research report has been prepared and distributed by Edelweiss Broking Limited ("Edelweiss") in the capacity of a Research Analyst as per Regulation 22(1) of SEBI (Research Analysts) Regulations 2014 having SEBI Registration No.INH000000172. 6 GWM